R
The California Supreme Court is set to review whether drug manufacturers like Gilead Sciences have a legal obligation to continue developing allegedly safer alternatives for their products, following a case where 24,000 HIV patients claim Gilead neglected to pursue a newer drug with fewer side effects in favor of maximizing profits from an existing medication. #PharmaceuticalIndustry #ProductLiability #Innovation #US
www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.